DK

Devaraj Krishnarajapuram Venkateshappa

Active Director Director DIN 11064796
DIN 11064796 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Devaraj Krishnarajapuram Venkateshappa

Data last updated:

Devaraj Krishnarajapuram Venkateshappa is a Director at Spinex Healthcare Private Limited (since 2025).

DIN 11064796
Primary Designation Director
First Appointment 19 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spinex Healthcare Private Limited U21002KA2025PTC201600
Director19 Apr 20252025Active

Board colleagues of Devaraj Krishnarajapuram Venkateshappa

NameDINCompanyDesignation
Deepika Dinesh07965433Spinex Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Spinex Healthcare Private Limited
Premium access

Shareholding and investment profile for Devaraj Krishnarajapuram Venkateshappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devaraj Krishnarajapuram Venkateshappa

Devaraj Krishnarajapuram Venkateshappa currently holds 1 directorship: Spinex Healthcare Private Limited (Director, since 19 Apr 2025).

Devaraj Krishnarajapuram Venkateshappa was first appointed on 19 Apr 2025 as Director at Spinex Healthcare Private Limited.

The current boards of Devaraj Krishnarajapuram Venkateshappa's companies include Deepika Dinesh (Spinex Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available